Announcements Trials
Browse Landscape

Phase

Phase NA 19Phase 3 7Phase 4 4Phase 2 4Phase 1 2Phase 2/3 1Phase 1/2 1

Status

Completed 3Unknown 2Terminated 1Not yet recruiting 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other solid neoplasm 1Head & Neck 1Endocrine 1

Conditions

Thyroid Cancer, Papillary 1Head and Neck Neoplasms 1Advanced Malignant Solid Tumor 1

Interventions

Cyclophosphamide 51fludarabine 38Injections 32Gemcitabine 25Paclitaxel 24Cisplatin 22Radiotherapy 19toripalimab 18pembrolizumab 18Carboplatin 17Capecitabine 17Fluorouracil 15Oxaliplatin 14Nivolumab 14Docetaxel 12camrelizumab 11apatinib 11Temozolomide 11Immunotherapy, Adoptive 11Cetuximab 11Bevacizumab 10Irinotecan 9Drug Therapy 9sintilimab 8Etoposide 8aldesleukin 7Taxes 7Rituximab 7Radiosurgery 7Peripheral Blood Stem Cell Transplantation 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × Unknown × Radiofrequency Ablation × Clear all
NCT04864379 2021-04-28

Clinical Study of a Personalized Neoantigen Cancer Vaccine Combined With Anti-PD-1 and RFA in Patients With Solid Tumors

Sir Run Run Shaw Hospital

Phase 1 Unknown
30 enrolled
Other solid neoplasm

Advanced Malignant Solid Tumor

NCT00103155 2013-09-20

Radiofrequency Ablation in Treating Patients Who Are Undergoing Surgery for Thyroid Cancer

National Cancer Institute (NCI)

Phase 1 Unknown
EndocrineHead & Neck

Thyroid Cancer, Papillary, Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡